Comprehensive Clinical Development Finalizes Acquisition of Charles River Clinical Services

Comprehensive Clinical Development, formerly operating as Comprehensive NeuroScience, Inc., announced today the acquisition of Charles River Clinical Services Northwest, Inc., including its 250-bed, 77,000-square-foot, Phase I-IIa facility located in Tacoma, Washington.

The increased capacity and capabilities deliver numerous benefits to support clients’ complete drug development programs, including:

• Geographic diversification allowing clients a more proximal location to conduct studies and increase service offerings from coast to coast

• Established experience in conducting radiolabeled studies

• Streamlined optimization and extensive expertise in biologics studies

• Access to leading physicians in numerous specialties including oncology, expansive patient populations and unique nuclear pharmacy capabilities, allowing for highly differentiated studies

• Specialized pharmacy services optimized for compounding, including radiolabeled compounds

• Extensive access to populations for targeting treatments for patients with Hepatitis C